DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo


145.04 -4.87 (-3.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $145.04 -3.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $148.93
Previous Close $149.91
Daily Range $143.69 - $149.39
52-Week Range $130.09 - $181.81
Market Cap $109.4B
P/E Ratio 14.44
Dividend (Yield) $4.00 (2.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,451,579
Average Daily Volume 3,980,439
Current FY EPS $10.05




Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Will 2016 Be Amgen Inc.'s Best Year Yet?

Amgen garnered a half-dozen drug approvals between December 2014 and the end of 2015, and the company delivered record full-year sales and profits in 2015. Could 2016 prove even better?

Amgen's Blincyto and Repatha Positive in Phase III Studies

Leerink Is Back On Board The Biotech Train

Samsung Bioepis And Biogen: A Profitable Case For SB2 And Enbrel

Gilead Reports Record Results, Street Remains Bored: Why? What's Next?

Why NantKwest Shares Fell 41% in January

Billionaire Patrick Soon-Shiong hopes to change cancer treatment forever.

Plenty of Opportunity to Buy Individual Stocks: John Buckingham

Noteworthy ETF Outflows: IUSG, AMGN, UNP, RAI

Is The Biotech Sector Bottoming Out?

23 Stocks For February 2016

See More AMGN News...

AMGN's Top Competitors

AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
CELG $97.89 (-3.96%)
Current stock: CELG
$0.00 (0.00%)
Current stock: